# Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

> clinical trial · VERIFIED · 2026-08-14

Status: ACTIVE_NOT_RECRUITING · Sponsor: Northwestern University · Condition: Hepatocellular Carcinoma

- Company: Northwestern University
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT04550481

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.